Inventiva announces positive topline results from the invest

Inventiva announces positive topline results from the investigator-initiated Phase II clinical trial evaluating lanifibranor in patients with T2D and NAFLD

Inventiva announces positive topline results from the investigator-initiated Phase II clinical trial evaluating lanifibranor in patients with T2D and NAFLD

itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Daix , Bourgogne , France , Paris , France General , New York , United States , Ukraine , Russia , Pascaline Clerc , Aude Lepreux , Michael Cooreman , Division Of Endocrinology , Global External Affairs , University Of Florida , Nasdaq , Exchange Commission On , Patricial Bank , Brunswick Group , Department Of Medicine , Long Island City , Euronext Paris , Kenneth Cusi , Intra Hepatic Triglycerides , Chief Medical Officer , Principal Investigator , Analysis Set , Hepatic Insulin Resistance , Breakthrough Therapy , Fast Track , Nasdaq Global Market , Global External , Roquet Montegon , Private Securities Litigation Reform Act , New Drug Application , Universal Registration Document , Des March , Annual Report , Exchange Commission ,